Clinical trial demonstrates significant hair regrowth using daily oral medication
A global trial evaluated the arthritis drug upadacitinib in patients suffering from extensive hair loss. By suppressing specific immune responses targeting hair follicles, approximately half of the participants regained at least eighty percent of their scalp hair over twenty four weeks. The findings offer a potential therapeutic path for severe alopecia.
